You are here

Article info

Article menu
Oncolytic and local immunotherapy
Original research
Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer

Authors

  • Daniel Alonso-Miguel Department of Animal Medicine, Surgery and Pathology, Mammary Oncology Unit, Veterinary Teaching Hospital, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain PubMed articlesGoogle scholar articles
  • Guillermo Valdivia Department of Animal Medicine, Surgery and Pathology, Mammary Oncology Unit, Veterinary Teaching Hospital, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain PubMed articlesGoogle scholar articles
  • Diego Guerrera Institute of Laboratory Animal Science, University of Zurich, Schlieren, Switzerland PubMed articlesGoogle scholar articles
  • Maria Dolores Perez-Alenza Department of Animal Medicine, Surgery and Pathology, Mammary Oncology Unit, Veterinary Teaching Hospital, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain PubMed articlesGoogle scholar articles
  • Stanislav Pantelyushin Institute of Laboratory Animal Science, University of Zurich, Schlieren, Switzerland PubMed articlesGoogle scholar articles
  • Angela Alonso-Diez Department of Animal Medicine, Surgery and Pathology, Mammary Oncology Unit, Veterinary Teaching Hospital, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain PubMed articlesGoogle scholar articles
  • Veronique Beiss Department of Biomedical Engineering, Case Western Reserve University School of Medicine, Cleveland, Ohio, USADepartment of NannoEngineering, University of California San Diego, La Jolla, California, USA PubMed articlesGoogle scholar articles
  • Steven Fiering Department of Microbiology and Immunology, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Health, Dartmouth College Geisel School of Medicine, Lebanon, New Hampshire, USA PubMed articlesGoogle scholar articles
  • Nicole F Steinmetz Department of Biomedical Engineering, Case Western Reserve University School of Medicine, Cleveland, Ohio, USADepartment of NannoEngineering, University of California San Diego, La Jolla, California, USADepartment of Radiology, University of California San Diego, La Jolla, California, USADepartment of Bioengineering, University of California San Diego, La Jolla, California, USAMoores Cancer Center, University of California San Diego, La Jolla, California, USACenter for Nano-ImmunoEngineering, University of California San Diego, La Jolla, California, USAInstitute for Materials Discovery and Design, University of California San Diego, La Jolla, California, USA PubMed articlesGoogle scholar articles
  • Maria Suarez-Redondo Department of Animal Medicine, Surgery and Pathology, Mammary Oncology Unit, Veterinary Teaching Hospital, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain PubMed articlesGoogle scholar articles
  • Johannes vom Berg Institute of Laboratory Animal Science, University of Zurich, Schlieren, Switzerland PubMed articlesGoogle scholar articles
  • Laura Peña Department of Animal Medicine, Surgery and Pathology, Mammary Oncology Unit, Veterinary Teaching Hospital, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain PubMed articlesGoogle scholar articles
  • Hugo Arias-Pulido Department of Microbiology and Immunology, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Health, Dartmouth College Geisel School of Medicine, Lebanon, New Hampshire, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Hugo Arias-Pulido; hugo.ariaspulido{at}dartmouth.edu
View Full Text

Citation

Alonso-Miguel D, Valdivia G, Guerrera D, et al
Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer
Journal for ImmunoTherapy of Cancer 2022;10:e004044. doi: 10.1136/jitc-2021-004044

Publication history

  • Accepted February 5, 2022
  • First published March 11, 2022.
Online issue publication 
March 11, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.